Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis.

NCT01641393 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Exocrine Pancreatic Insufficiency: Cystic Fibrosis

Interventions

DRUG: EUR-1008 25,000 Units
DRUG: Kreon 25,000 Units

Sponsor

Forest Laboratories